{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T19:38:58Z","timestamp":1777837138353,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771003"],"award-info":[{"award-number":["31771003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31400789"],"award-info":[{"award-number":["31400789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12934-019-1115-z","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T14:03:14Z","timestamp":1554386594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route"],"prefix":"10.1186","volume":"18","author":[{"given":"Xingmei","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JingPing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"1115_CR1","doi-asserted-by":"publisher","first-page":"181646","DOI":"10.1155\/2011\/181646","volume":"2011","author":"A Salvador","year":"2011","unstructured":"Salvador A, Igartua M, Hernandez RM, Pedraz JL. An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccines. J Drug Deliv. 2011;2011:181646.","journal-title":"J Drug Deliv"},{"key":"1115_CR2","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","volume":"25","author":"JC Aguilar","year":"2007","unstructured":"Aguilar JC, Rodriguez EG. Vaccine adjuvants revisited. Vaccine. 2007;25:3752\u201362.","journal-title":"Vaccine"},{"key":"1115_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4155\/ppa.15.38","volume":"5","author":"AS Cordeiro","year":"2016","unstructured":"Cordeiro AS, Alonso MJ. Recent advances in vaccine delivery. Pharm Pat Anal. 2016;5:49\u201373.","journal-title":"Pharm Pat Anal"},{"key":"1115_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tips.2017.06.002","volume":"38","author":"SR Bonam","year":"2017","unstructured":"Bonam SR, Partidos CD, Halmuthur SKM, Muller S. An overview of novel adjuvants designed for improving vaccine efficacy. Trends Pharmacol Sci. 2017;38:771\u201393.","journal-title":"Trends Pharmacol Sci"},{"key":"1115_CR5","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.2217\/nnm.14.187","volume":"9","author":"M Skwarczynski","year":"2014","unstructured":"Skwarczynski M, Toth I. Recent advances in peptide-based subunit nanovaccines. Nanomedicine (Lond). 2014;9:2657\u201369.","journal-title":"Nanomedicine (Lond)"},{"key":"1115_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2217\/17435889.3.3.343","volume":"3","author":"TM Fahmy","year":"2008","unstructured":"Fahmy TM, Demento SL, Caplan MJ, Mellman I, Saltzman WM. Design opportunities for actively targeted nanoparticle vaccines. Nanomedicine (Lond). 2008;3:343\u201355.","journal-title":"Nanomedicine (Lond)"},{"key":"1115_CR7","doi-asserted-by":"publisher","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","volume":"115","author":"DJ Irvine","year":"2015","unstructured":"Irvine DJ, Hanson MC, Rakhra K, Tokatlian T. Synthetic nanoparticles for vaccines and immunotherapy. Chem Rev. 2015;115:11109\u201346.","journal-title":"Chem Rev"},{"key":"1115_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","volume":"4","author":"A Vartak","year":"2016","unstructured":"Vartak A, Sucheck SJ. Recent advances in subunit vaccine carriers. Vaccines (Basel). 2016;4:12.","journal-title":"Vaccines (Basel)"},{"key":"1115_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/all.13199","volume":"72","author":"H Pohlit","year":"2017","unstructured":"Pohlit H, Bellinghausen I, Frey H, Saloga J. Recent advances in the use of nanoparticles for allergen-specific immunotherapy. Allergy. 2017;72:1461\u201374.","journal-title":"Allergy"},{"key":"1115_CR10","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/eji.200526285","volume":"35","author":"P Maurer","year":"2005","unstructured":"Maurer P, Jennings GT, Willers J, Rohner F, Lindman Y, Roubicek K, Renner WA, Muller P, Bachmann MF. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity. Eur J Immunol. 2005;35:2031\u201340.","journal-title":"Eur J Immunol"},{"key":"1115_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nnano.2007.223","volume":"2","author":"MA Dobrovolskaia","year":"2007","unstructured":"Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat Nanotechnol. 2007;2:469\u201378.","journal-title":"Nat Nanotechnol"},{"key":"1115_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/wnan.119","volume":"3","author":"EM Plummer","year":"2011","unstructured":"Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:174\u201396.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1115_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2012.04.047","volume":"440","author":"JF Correia-Pinto","year":"2013","unstructured":"Correia-Pinto JF, Csaba N, Alonso MJ. Vaccine delivery carriers: insights and future perspectives. Int J Pharm. 2013;440:27\u201338.","journal-title":"Int J Pharm"},{"key":"1115_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nbt0612-471","volume":"30","author":"C Sheridan","year":"2012","unstructured":"Sheridan C. Proof of concept for next-generation nanoparticle drugs in humans. Nat Biotechnol. 2012;30:471\u20133.","journal-title":"Nat Biotechnol"},{"key":"1115_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1389201015666141202110919","volume":"16","author":"AL Mateescu","year":"2015","unstructured":"Mateescu AL, Dimov TV, Grumezescu AM, Gestal MC, Chifiriuc MC. Nanostructured bioactive polymers used in food-packaging. Curr Pharm Biotechnol. 2015;16:121\u20137.","journal-title":"Curr Pharm Biotechnol"},{"key":"1115_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","volume":"32","author":"L Zhao","year":"2014","unstructured":"Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg AP. Nanoparticle vaccines. Vaccine. 2014;32:327\u201337.","journal-title":"Vaccine"},{"key":"1115_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/156720111795256192","volume":"8","author":"M Skwarczynski","year":"2011","unstructured":"Skwarczynski M, Toth I. Peptide-based subunit nanovaccines. Curr Drug Deliv. 2011;8:282\u20139.","journal-title":"Curr Drug Deliv"},{"key":"1115_CR18","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1016\/j.biomaterials.2010.04.008","volume":"31","author":"C Diez-Gil","year":"2010","unstructured":"Diez-Gil C, Krabbenborg S, Garcia-Fruitos E, Vazquez E, Rodriguez-Carmona E, Ratera I, Ventosa N, Seras-Franzoso J, Cano-Garrido O, Ferrer-Miralles N, et al. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials. 2010;31:5805\u201312.","journal-title":"Biomaterials"},{"key":"1115_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1042\/BA20070140","volume":"49","author":"S Peternel","year":"2008","unstructured":"Peternel S, Jevsevar S, Bele M, Gaberc-Porekar V, Menart V. New properties of inclusion bodies with implications for biotechnology. Biotechnol Appl Biochem. 2008;49:239\u201346.","journal-title":"Biotechnol Appl Biochem"},{"key":"1115_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1475-2859-9-66","volume":"9","author":"S Peternel","year":"2010","unstructured":"Peternel S, Komel R. Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells. Microb Cell Fact. 2010;9:66.","journal-title":"Microb Cell Fact"},{"key":"1115_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fmicb.2014.00056","volume":"5","author":"A Ramon","year":"2014","unstructured":"Ramon A, Senorale-Pose M, Marin M. Inclusion bodies: not that bad. Front Microbiol. 2014;5:56.","journal-title":"Front Microbiol"},{"key":"1115_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1475-2859-9-71","volume":"9","author":"E Rodriguez-Carmona","year":"2010","unstructured":"Rodriguez-Carmona E, Cano-Garrido O, Seras-Franzoso J, Villaverde A, Garcia-Fruitos E. Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact. 2010;9:71.","journal-title":"Microb Cell Fact"},{"key":"1115_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.nbt.2011.09.005","volume":"30","author":"S Peternel","year":"2013","unstructured":"Peternel S. Bacterial cell disruption: a crucial step in protein production. N Biotechnol. 2013;30:250\u20134.","journal-title":"N Biotechnol"},{"key":"1115_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2859-7-34","volume":"7","author":"S Peternel","year":"2008","unstructured":"Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact. 2008;7:34.","journal-title":"Microb Cell Fact"},{"key":"1115_CR25","first-page":"77","volume":"1","author":"MK Purcell","year":"2006","unstructured":"Purcell MK, Smith KD, Hood L, Winton JR, Roach JC. Conservation of toll-like receptor signaling pathways in teleost fish. Comp Biochem Physiol Part D Genom Proteom. 2006;1:77\u201388.","journal-title":"Comp Biochem Physiol Part D Genom Proteom"},{"key":"1115_CR26","doi-asserted-by":"publisher","first-page":"e0164073","DOI":"10.1371\/journal.pone.0164073","volume":"11","author":"D Torrealba","year":"2016","unstructured":"Torrealba D, Seras-Franzoso J, Mamat U, Wilke K, Villaverde A, Roher N, Garcia-Fruitos E. Complex particulate biomaterials as immunostimulant-delivery platforms. PLoS ONE. 2016;11:e0164073.","journal-title":"PLoS ONE"},{"key":"1115_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/vim.2017.0026","volume":"30","author":"T Aoshi","year":"2017","unstructured":"Aoshi T. Modes of action for mucosal vaccine adjuvants. Viral Immunol. 2017;30:463\u201370.","journal-title":"Viral Immunol"},{"key":"1115_CR28","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1039\/C5SM02930A","volume":"12","author":"J Seras-Franzoso","year":"2016","unstructured":"Seras-Franzoso J, Sanchez-Chardi A, Garcia-Fruitos E, Vazquez E, Villaverde A. Cellular uptake and intracellular fate of protein releasing bacterial amyloids in mammalian cells. Soft Matter. 2016;12:3451\u201360.","journal-title":"Soft Matter"},{"key":"1115_CR29","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/adma.201104330","volume":"24","author":"E Vazquez","year":"2012","unstructured":"Vazquez E, Corchero JL, Burgueno JF, Seras-Franzoso J, Kosoy A, Bosser R, Mendoza R, Martinez-Lainez JM, Rinas U, Fernandez E, et al. Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv Mater. 2012;24:1742\u20137.","journal-title":"Adv Mater"},{"key":"1115_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2221-1691(11)60213-X","volume":"2","author":"O Khow","year":"2012","unstructured":"Khow O, Suntrarachun S. Strategies for production of active eukaryotic proteins in bacterial expression system. Asian Pac J Trop Biomed. 2012;2:159\u201362.","journal-title":"Asian Pac J Trop Biomed"},{"key":"1115_CR31","first-page":"63","volume":"5","author":"S Costa","year":"2014","unstructured":"Costa S, Almeida A, Castro A, Domingues L. Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system. Front Microbiol. 2014;5:63.","journal-title":"Front Microbiol"},{"key":"1115_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/biot.201100331","volume":"7","author":"F Khan","year":"2012","unstructured":"Khan F, Legler PM, Mease RM, Duncan EH, Bergmann-Leitner ES, Angov E. Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice. Biotechnol J. 2012;7:133\u201347.","journal-title":"Biotechnol J"},{"key":"1115_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1107\/S2053230X14026788","volume":"71","author":"G Zhao","year":"2015","unstructured":"Zhao G, Jin Z, Allewell NM, Tuchman M, Shi D. Structures of the N-acetyltransferase domain of Xylella fastidiosa N-acetyl-l-glutamate synthase\/kinase with and without a His tag bound to N-acetyl-l-glutamate. Acta Crystallogr F Struct Biol Commun. 2015;71:86\u201395.","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"1115_CR34","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s10529-014-1509-2","volume":"36","author":"D Guan","year":"2014","unstructured":"Guan D, Chen Z. Challenges and recent advances in affinity purification of tag-free proteins. Biotechnol Lett. 2014;36:1391\u2013406.","journal-title":"Biotechnol Lett"},{"key":"1115_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pep.2005.12.002","volume":"48","author":"J Arnau","year":"2006","unstructured":"Arnau J, Lauritzen C, Petersen GE, Pedersen J. Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. Protein Expr Purif. 2006;48:1\u201313.","journal-title":"Protein Expr Purif"},{"key":"1115_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1387-2656(04)10002-1","volume":"10","author":"LD Cabrita","year":"2004","unstructured":"Cabrita LD, Bottomley SP. Protein expression and refolding\u2014a practical guide to getting the most out of inclusion bodies. Biotechnol Annu Rev. 2004;10:31\u201350.","journal-title":"Biotechnol Annu Rev"},{"key":"1115_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng. 2005;99:303\u201310.","journal-title":"J Biosci Bioeng"},{"key":"1115_CR38","doi-asserted-by":"crossref","first-page":"pdb prot5485","DOI":"10.1101\/pdb.prot5485","volume":"2010","author":"RJ Simpson","year":"2010","unstructured":"Simpson RJ. Solubilization of Escherichia coli recombinant proteins from inclusion bodies. Cold Spring Harb Protoc. 2010;2010:pdb prot5485.","journal-title":"Cold Spring Harb Protoc"},{"key":"1115_CR39","first-page":"43","volume":"205","author":"MQ Xu","year":"2003","unstructured":"Xu MQ, Evans TC. Purification of recombinant proteins from E. coli by engineered inteins. Methods Mol Biol. 2003;205:43\u201368.","journal-title":"Methods Mol Biol"},{"key":"1115_CR40","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1093\/nar\/26.22.5109","volume":"26","author":"S Chong","year":"1998","unstructured":"Chong S, Montello GE, Zhang A, Cantor EJ, Liao W, Xu MQ, Benner J. Utilizing the C-terminal cleavage activity of a protein splicing element to purify recombinant proteins in a single chromatographic step. Nucleic Acids Res. 1998;26:5109\u201315.","journal-title":"Nucleic Acids Res"},{"key":"1115_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0378-1119(97)00105-4","volume":"192","author":"S Chong","year":"1997","unstructured":"Chong S, Mersha FB, Comb DG, Scott ME, Landry D, Vence LM, Perler FB, Benner J, Kucera RB, Hirvonen CA, et al. Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element. Gene. 1997;192:271\u201381.","journal-title":"Gene"},{"key":"1115_CR42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ab.2006.04.055","volume":"356","author":"KV Mills","year":"2006","unstructured":"Mills KV, Connor KR, Dorval DM, Lewandowski KT. Protein purification via temperature-dependent, intein-mediated cleavage from an immobilized metal affinity resin. Anal Biochem. 2006;356:86\u201393.","journal-title":"Anal Biochem"},{"key":"1115_CR43","doi-asserted-by":"publisher","first-page":"14512","DOI":"10.1074\/jbc.R114.552653","volume":"289","author":"DW Wood","year":"2014","unstructured":"Wood DW, Camarero JA. Intein applications: from protein purification and labeling to metabolic control methods. J Biol Chem. 2014;289:14512\u20139.","journal-title":"J Biol Chem"},{"key":"1115_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pep.2006.05.019","volume":"50","author":"C Cui","year":"2006","unstructured":"Cui C, Zhao W, Chen J, Wang J, Li Q. Elimination of in vivo cleavage between target protein and intein in the intein-mediated protein purification systems. Protein Expr Purif. 2006;50:74\u201381.","journal-title":"Protein Expr Purif"},{"key":"1115_CR45","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/j.febslet.2011.06.035","volume":"585","author":"X Qi","year":"2011","unstructured":"Qi X, Meng Q, Liu XQ. Spontaneous C-cleavage of a mini-intein without its conserved N-terminal motif A. FEBS Lett. 2011;585:2513\u20138.","journal-title":"FEBS Lett"},{"key":"1115_CR46","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","volume":"32","author":"A Lamichhane","year":"2014","unstructured":"Lamichhane A, Azegamia T, Kiyonoa H. The mucosal immune system for vaccine development. Vaccine. 2014;32:6711\u201323.","journal-title":"Vaccine"},{"key":"1115_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006;6:148\u201358.","journal-title":"Nat Rev Immunol"},{"key":"1115_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2014010102","volume":"31","author":"H Patel","year":"2014","unstructured":"Patel H, Yewale C, Rathi MN, Misra A. Mucosal immunization: a review of strategies and challenges. Crit Rev Ther Drug Carrier Syst. 2014;31:273\u2013303.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"1115_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.biomaterials.2016.08.043","volume":"107","author":"D Torrealba","year":"2016","unstructured":"Torrealba D, Parra D, Seras-Franzoso J, Vallejos-Vidal E, Yero D, Gibert I, Villaverde A, Garcia-Fruitos E, Roher N. Nanostructured recombinant cytokines: a highly stable alternative to short-lived prophylactics. Biomaterials. 2016;107:102\u201314.","journal-title":"Biomaterials"},{"key":"1115_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0014-5793(90)80388-Y","volume":"271","author":"Y Shirano","year":"1990","unstructured":"Shirano Y, Shibata D. Low temperature cultivation of Escherichia coli carrying a rice lipoxygenase L-2 cDNA produces a soluble and active enzyme at a high level. FEBS Lett. 1990;271:128\u201330.","journal-title":"FEBS Lett"},{"key":"1115_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-4939-3637-3_3","volume":"1432","author":"F Angius","year":"2016","unstructured":"Angius F, Ilioaia O, Uzan M, Miroux B. membrane protein production in Escherichia coli: protocols and rules. Methods Mol Biol. 2016;1432:37\u201352.","journal-title":"Methods Mol Biol"},{"key":"1115_CR52","doi-asserted-by":"publisher","first-page":"e86656","DOI":"10.1371\/journal.pone.0086656","volume":"9","author":"SE Howe","year":"2014","unstructured":"Howe SE, Lickteig DJ, Plunkett KN, Ryerse JS, Konjufca V. The uptake of soluble and particulate antigens by epithelial cells in the mouse small intestine. PLoS ONE. 2014;9:e86656.","journal-title":"PLoS ONE"},{"key":"1115_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.nano.2011.08.009","volume":"8","author":"A Awaad","year":"2012","unstructured":"Awaad A, Nakamura M, Ishimura K. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer\u2019s patches using fluorescent organosilica particles. Nanomedicine. 2012;8:627\u201336.","journal-title":"Nanomedicine"},{"key":"1115_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.chroma.2005.11.048","volume":"1120","author":"J Luo","year":"2006","unstructured":"Luo J, Leeman M, Ballagi A, Elfwing A, Su Z, Janson JC, Wahlund KG. Size characterization of green fluorescent protein inclusion bodies in E. coli using asymmetrical flow field-flow fractionation-multi-angle light scattering. J Chromatogr A. 2006;1120:158\u201364.","journal-title":"J Chromatogr A"},{"key":"1115_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jbiotec.2008.07.1995","volume":"138","author":"G Margreiter","year":"2008","unstructured":"Margreiter G, Messner P, Caldwell KD, Bayer K. Size characterization of inclusion bodies by sedimentation field-flow fractionation. J Biotechnol. 2008;138:67\u201373.","journal-title":"J Biotechnol"},{"key":"1115_CR56","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000237177","volume":"108","author":"C Ruedl","year":"1995","unstructured":"Ruedl C, Wolf H. Features of oral immunization. Int Arch Allergy Immunol. 1995;108:334\u20139.","journal-title":"Int Arch Allergy Immunol"},{"key":"1115_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.imlet.2003.12.001","volume":"91","author":"M Kesik","year":"2004","unstructured":"Kesik M, Saczynska V, Szewczyk B, Plucienniczak A. Inclusion bodies from recombinant bacteria as a novel system for delivery of vaccine antigen by the oral route. Immunol Lett. 2004;91:197\u2013204.","journal-title":"Immunol Lett"},{"key":"1115_CR58","doi-asserted-by":"publisher","first-page":"41485","DOI":"10.1038\/srep41485","volume":"7","author":"X Qi","year":"2017","unstructured":"Qi X, Xiong S. Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis. Sci Rep. 2017;7:41485.","journal-title":"Sci Rep"},{"key":"1115_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12934-015-0208-6","volume":"14","author":"X Qi","year":"2015","unstructured":"Qi X, Sun Y, Xiong S. A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form. Microb Cell Fact. 2015;14:24.","journal-title":"Microb Cell Fact"},{"key":"1115_CR60","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1021\/nn403085w","volume":"7","author":"NM Molino","year":"2013","unstructured":"Molino NM, Anderson AK, Nelson EL, Wang SW. Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. ACS Nano. 2013;7:9743\u201352.","journal-title":"ACS Nano"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-019-1115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12934-019-1115-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-019-1115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T07:24:33Z","timestamp":1663226673000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-019-1115-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1186\/s12934-019-1115-z","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"18 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"66"}}